217453-46-8Relevant articles and documents
Antiviral agent for hepatitis B virus infection
-
Paragraph 0017- 0020, (2020/07/21)
The invention discloses an antiviral agent for hepatitis B virus infection. The antiviral agent comprises pharmaceutically acceptable salts, esters, prodrugs, complexes, solvates, hydrates or isomersof the antiviral agent, and application of the antiviral
Antiviral agent for hepatitis B virus infection
-
Paragraph 0017-0020, (2020/07/15)
The invention discloses an antiviral agent for hepatitis B virus infection, and relates to pharmaceutically acceptable salts, esters, prodrugs, complexes, solvates, hydrates or isomers of the antiviral agent, and an application of the antiviral agent in p
3-AMIDINOANILINE DERIVATIVES, ACTIVATED BLOOD COAGULATION FACTOR X INHIBITORS, AND INTERMEDIATES FOR PRODUCING BOTH
-
, (2008/06/13)
The present invention relates to a 3-amidinoaniline derivative represented by the general formula: wherein R represents a hydrogen atom, a lower alkyl group, a lower alkenyl group etc.; R1 represents a hydrogen atom, a hydroxy group, a lower alkyl group etc.; Y represents a single bond or an oxygen atom; and R2 represents a lower alkyl group or a group represented by the general formula: wherein n represents 1 or 2; and T represents a hydrogen atom or a group represented by the general formula:-C(=NH)-W wherein W represents a lower alkyl group; or a pharmaceutically acceptable salt thereof, which has a potent and selective activated blood coagulation factor X inhibitory activity, and an intermediate for producing both.
